Real-World Evidence for the Tolerance and Effectiveness of the First Drug (Sacubitril/Valsartan) in a New Class-ARN in Afro-Caribbean Patients with Heart Failure with Reduced Ejection Fraction

Felix Nunura^1*, Edwin Tulloch-Reid², Daniel Nepaul³, Dainia S Baugh³ and Ernest C Madu¹

¹Division of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica

²Department of Interventional Cardiology, Heart Institute of the Caribbean, Kingston, Jamaica

³Department of Medicine, Heart Institute of the Caribbean, Kingston, Jamaica

^*Corresponding Author: Felix Nunura, Division of Cardiovascular Medicine, Heart Institute of the Caribbean, Kingston, Jamaica, Tel: +18769062105 Email: